Sujal Shah

Insider Reports History

Entity
Individual
Location
C/O Cymabay Therapeutics, Inc., 7575 Gateway Blvd., Suite 110, Newark, CA
Signature
/s/ Paul Quinlan, as attorney in fact for Sujal Shah
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sujal Shah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CymaBay Therapeutics, Inc. Chief Executive Officer, Director Common Stock 0 $0 $2.94 Mar 22, 2024 Direct
CymaBay Therapeutics, Inc. Chief Executive Officer, Director Stock Appreciation Right 0 Dec 11, 2023 Direct
CymaBay Therapeutics, Inc. Chief Executive Officer, Director Employee Stock Option (right to buy) 0 Mar 22, 2024 Direct

Insider Reports Filed by Sujal Shah

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CBAY CymaBay Therapeutics, Inc. Mar 22, 2024 15 $0 4 Mar 22, 2024 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Mar 13, 2024 18 $656K 4 Mar 15, 2024 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Jan 24, 2024 2 $0 4 Jan 26, 2024 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Dec 11, 2023 7 -$973K 4 Dec 11, 2023 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Nov 13, 2023 7 -$706K 4 Nov 14, 2023 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Oct 9, 2023 5 -$597K 4 Oct 10, 2023 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Jan 25, 2023 1 $0 4 Jan 27, 2023 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Jun 6, 2022 1 $100K 4 Jun 7, 2022 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Jan 25, 2022 1 $0 4 Jan 27, 2022 Chief Executive Officer, Director